Results 121 to 130 of about 9,420 (171)

Long-Term Survival following Trimodal Therapy Including Hyperfractionated Radiotherapy in Parotid NUT Carcinoma: A 29-Month Follow-Up Case Report. [PDF]

Case Rep Oncol
Besserer A, Mutiara S, Breywisch F, Jungehülsing M, Höcht S.   +4 more
europepmc   +1 more source

Nationwide retrospective study on the prevalence and prognostic factors of NUT carcinoma in the United States. [PDF]

Ann Med Surg (Lond)
Arabi TZ, Sabbah BN, Razak A, Alaswad M, Maklad AE, Aleem MU, Ouban A.   +6 more
europepmc   +1 more source

Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients. [PDF]

NPJ Precis Oncol
Haebe S, Schuebbe G, Jurmeister P, von Bergwelt-Baildon M, Westphalen CB, Lauer UM, Kunz WG, Subklewe M, Weigert O.   +8 more
europepmc   +1 more source

Maxillary Sinus NUT Carcinoma: A Case Report. [PDF]

Cancer Diagn Progn
Arai S, Tomioka R, Ueda Y, Shimizu A, Okamoto I, Tsukahara K.   +5 more
europepmc   +1 more source

Consolidation immunotherapy following concurrent chemoradiotherapy in a patient with sinonasal NUT carcinoma: a case report. [PDF]

Front Oncol
Geng X, Chang X, Wang X, Li S, Han G, Song Z, Hao F, Li J.   +7 more
europepmc   +1 more source

Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck. [PDF]

Nat Rev Clin Oncol
Luo J, Bishop JA, DuBois SG, Hanna GJ, Sholl LM, Stelow EB, Thompson LDR, Shapiro GI, French CA.   +8 more
europepmc   +1 more source

Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma. [PDF]

J Thorac Oncol
Luo J, Sanchez M, Lee E, Hertzler H, Luong N, Mazzola E, Finstein B, Tamen R, Brisbane G, Nguyen T, Paik PK, Chaft JE, Cheng ML, Khalil H, Piha-Paul SA, Sholl LM, Nishino M, Jänne PA, DuBois SG, Hanna GJ, Shapiro GI, French CA.   +21 more
europepmc   +1 more source

Primary cutaneous NUT adnexal carcinoma: morphologic, genetic and methylation analysis of seven new cases with comparison to extracutaneous NUT carcinoma and NUTM1-rearranged porocarcinoma. [PDF]

Histopathology
Legrand M, Louveau B, Osio A, Tallet A, Calonje E, Scoazec JY, de la Fouchardiere A, Tirode F, Von Deimling A, Busam K, Shah A, Shah A, Flaman A, Jouenne F, Mourah S, Pissaloux D, Lantuejoul S, French CA, Goto K, Goto K, Cribier B, Dehner CA, Alomari AK, Fletcher CD, Hanna J, Macagno N, Battistella M, Kervarrec T.   +27 more
europepmc   +1 more source

Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review. [PDF]

Front Immunol
Yang G, Liu R, Yang L, Yang X, Tang X, Mao H.   +5 more
europepmc   +1 more source

The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases. [PDF]

Histopathology
Viswanathan K, Hahn E, Dogan S, Weinreb I, Dickson BC, MacMillan C, Katabi N, Magliocca K, Ghossein R, Xu B.   +9 more
europepmc   +1 more source